Endpoints News 生物医药· Elizabeth Cairns·· 8 天前AI 评分30
Blackstone 投资 15 亿美元支持 Pfizer 肥胖候选药 Berobenatide 研发
Blackstone commits up to $1.5B for R&D of Pfizer's ex-Metsera GLP-1
AI 导读
Pfizer 获得投资集团 Blackstone 15 亿美元支持,用于其肥胖候选药 Berobenatide 的研发。
正文
Pfizer has secured up to $1.5 billion from the investment group Blackstone Life Sciences to help pay for the development of its obesity candidate berobenatide.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news